State Street’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $186M | Sell |
12,893,897
-1,939,417
| -13% | -$27.8M | 0.01% | 978 |
|
|
2025
Q4 | $211M | Buy |
14,833,314
+3,270,375
| +28% | +$32.1M | 0.01% | 907 |
|
|
2025
Q3 | $91.1M | Sell |
11,562,939
-5,158
| -0% | -$36.7K | ﹤0.01% | 1380 |
|
|
2025
Q2 | $66.3M | Buy |
11,568,097
+2,049,078
| +22% | +$13.2M | ﹤0.01% | 1532 |
|
|
2025
Q1 | $77.7M | Sell |
9,519,019
-842,209
| -8% | -$7.79M | ﹤0.01% | 1402 |
|
|
2024
Q4 | $97.6M | Sell |
10,361,228
-609,518
| -6% | -$6.34M | ﹤0.01% | 1349 |
|
|
2024
Q3 | $117M | Sell |
10,970,746
-46,217
| -0.4% | -$503K | ﹤0.01% | 1236 |
|
|
2024
Q2 | $109M | Sell |
11,016,963
-1,425,538
| -11% | -$14.6M | ﹤0.01% | 1202 |
|
|
2024
Q1 | $147M | Sell |
12,442,501
-720,584
| -5% | -$9.22M | 0.01% | 1063 |
|
|
2023
Q4 | $187M | Buy |
13,163,085
+1,790,649
| +16% | +$20.3M | 0.01% | 887 |
|
|
2023
Q3 | $138M | Buy |
11,372,436
+193,194
| +2% | +$2.49M | 0.01% | 966 |
|
|
2023
Q2 | $140M | Buy |
11,179,242
+48,357
| +0.4% | +$574K | 0.01% | 1004 |
|
|
2023
Q1 | $123M | Sell |
11,130,885
-954,954
| -8% | -$11.8M | 0.01% | 1049 |
|
|
2022
Q4 | $148M | Buy |
12,085,839
+63,627
| +0.5% | +$716K | 0.01% | 924 |
|
|
2022
Q3 | $126M | Sell |
12,022,212
-1,896,103
| -14% | -$21.1M | 0.01% | 977 |
|
|
2022
Q2 | $149M | Buy |
13,918,315
+1,983,752
| +17% | +$16.3M | 0.01% | 905 |
|
|
2022
Q1 | $113M | Buy |
11,934,563
+1,432,498
| +14% | +$13.4M | 0.01% | 1208 |
|
|
2021
Q4 | $121M | Buy |
10,502,065
+486,335
| +5% | +$5.42M | 0.01% | 1147 |
|
|
2021
Q3 | $95.7M | Buy |
10,015,730
+579,481
| +6% | +$5.93M | 0.01% | 1300 |
|
|
2021
Q2 | $91M | Sell |
9,436,249
-100,693
| -1% | -$983K | ﹤0.01% | 1368 |
|
|
2021
Q1 | $94.2M | Buy |
9,536,942
+1,627,551
| +21% | +$25.2M | 0.01% | 1276 |
|
|
2020
Q4 | $183M | Sell |
7,909,391
-1,019,668
| -11% | -$20.9M | 0.01% | 785 |
|
|
2020
Q3 | $126M | Sell |
8,929,059
-1,354,448
| -13% | -$19.7M | 0.01% | 855 |
|
|
2020
Q2 | $155M | Sell |
10,283,507
-845,644
| -8% | -$10.3M | 0.01% | 749 |
|
|
2020
Q1 | $103M | Buy |
11,129,151
+132,427
| +1% | +$1.26M | 0.01% | 839 |
|
|
2019
Q4 | $107M | Sell |
10,996,724
-584,457
| -5% | -$5.35M | 0.01% | 1000 |
|
|
2019
Q3 | $92.9M | Buy |
11,581,181
+1,783,202
| +18% | +$19.4M | 0.01% | 1047 |
|
|
2019
Q2 | $122M | Buy |
9,797,979
+1,134,496
| +13% | +$14.4M | 0.01% | 905 |
|
|
2019
Q1 | $118M | Buy |
8,663,483
+108,931
| +1% | +$1.33M | 0.01% | 909 |
|
|
2018
Q4 | $82M | Sell |
8,554,552
-936,561
| -10% | -$10.3M | 0.01% | 1026 |
|
|
2018
Q3 | $115M | Buy |
9,491,113
+1,528,657
| +19% | +$21.4M | 0.01% | 981 |
|
|
2018
Q2 | $124M | Sell |
7,962,456
-587,121
| -7% | -$8.88M | 0.01% | 893 |
|
|
2018
Q1 | $129M | Buy |
8,549,577
+711,125
| +9% | +$10.8M | 0.01% | 865 |
|
|
2017
Q4 | $113M | Sell |
7,838,452
-312,639
| -4% | -$4.3M | 0.01% | 959 |
|
|
2017
Q3 | $123M | Buy |
8,151,091
+2,258,527
| +38% | +$29.9M | 0.01% | 871 |
|
|
2017
Q2 | $59.3M | Buy |
5,892,564
+125,635
| +2% | +$1.01M | 0.01% | 1256 |
|
|
2017
Q1 | $41.1M | Buy |
5,766,929
+50,982
| +0.9% | +$322K | ﹤0.01% | 1445 |
|
|
2016
Q4 | $28.4M | Buy |
5,715,947
+622,349
| +12% | +$4.31M | ﹤0.01% | 1640 |
|
|
2016
Q3 | $37.7M | Buy |
5,093,598
+612,982
| +14% | +$4.14M | ﹤0.01% | 1366 |
|
|
2016
Q2 | $24.5M | Buy |
4,480,616
+661,186
| +17% | +$4.62M | ﹤0.01% | 1609 |
|
|
2016
Q1 | $32.3M | Sell |
3,819,430
-1,337,428
| -26% | -$9.47M | ﹤0.01% | 1403 |
|
|
2015
Q4 | $50M | Buy |
5,156,858
+1,769,519
| +52% | +$15.9M | 0.01% | 1178 |
|
|
2015
Q3 | $47.4M | Buy |
3,387,339
+110,300
| +3% | +$1.73M | 0.01% | 1207 |
|
|
2015
Q2 | $46.4M | Buy |
3,277,039
+845,810
| +35% | +$10.2M | 0.01% | 1319 |
|
|
2015
Q1 | $26.5M | Buy |
2,431,229
+296,438
| +14% | +$2.61M | ﹤0.01% | 1644 |
|
|
2014
Q4 | $17.8M | Buy |
2,134,791
+2,104,843
| +7,028% | +$14.4M | ﹤0.01% | 1885 |
|
|
2014
Q3 | $179K | Buy |
29,948
+1,100
| +4% | +$5.76K | ﹤0.01% | 3489 |
|
|
2014
Q2 | $97K | Sell |
28,848
-403,608
| -93% | -$947K | ﹤0.01% | 3471 |
|
|
2014
Q1 | $894K | Buy |
432,456
+4,718
| +1% | +$11.8K | ﹤0.01% | 3271 |
|
|
2013
Q4 | $1M | Sell |
427,738
-864
| -0.2% | -$1.9K | ﹤0.01% | 3254 |
|
|
2013
Q3 | $992K | Sell |
428,602
-1,087
| -0.3% | -$2.73K | ﹤0.01% | 3250 |
|
|
2013
Q2 | $1M | Buy |
+429,689
| New | +$1.32M | ﹤0.01% | 3187 |
|
Other funds holding FOLD
VCM
PCM
VPM
GCL
HI
State Street's FOLD Position: Q1 2026 in Review
State Street reduced its Amicus Therapeutics (FOLD) stake by 13% in Q1 2026, selling an estimated $27.8M and leaving 12,893,897 shares worth $186M. The position accounts for 0.01% of the portfolio, ranked #978.
State Street first reported a position in FOLD in Q2 2013 and has held it in 52 quarters since. The position peaked at $211M in Q4 2025. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.
- State Street held 12,893,897 shares of Amicus Therapeutics worth $186M as of Q1 2026.
- State Street sold 1,939,417 Amicus Therapeutics shares in Q1 2026, an estimated $27.8M.
- Amicus Therapeutics made up 0.01% of State Street's portfolio in Q1 2026, its #978 holding.
- State Street first reported a position in Amicus Therapeutics in Q2 2013 and has held it in 52 quarters since.
- State Street's Amicus Therapeutics position peaked at $211M in Q4 2025.
- 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.
Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.